Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited ('The Company') - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with ...

MUMBAI (Reuters) - Wockhardt Ltd(NSI:WOCKPHARMA) faces a sharp drop in market share and delays in new launch approvals after a second plant operated by the generic drugmaker was hit by the U.S. Food ...

It's strike three for India’s Wockhardt, which has had a third plant in its home country banned from exporting to the U.S. The FDA on Friday added Wockhardt’s bulk manufacturing plant in Ankleshwar, ...

Wockhardt Ltd that built its name as a maker of generic drugs is shifting its focus in the US market to developing new antibiotics, turning away from generics and entering a space largely vacated by ...

India’s Wockhardt, which has had its financial fortunes dampened for several years by FDA-related manufacturing issues, has decided to improve its cash flow by selling a plant and portfolio of ...

Wockhardt Ltd is quoting at Rs 1422, up 1.02% on the day as on 12:44 IST on the NSE. The stock is up 0.52% in last one year as compared to a 0.37% spurt in NIFTY and a 3.24% spurt in the Nifty Pharma.

MUMBAI (Reuters) - Drugmaker Wockhardt's steps to have the United States lift bans on products from two of its plants are unlikely to approved until next year, its chairman said on Monday after the ...

A federal judge has thrown out generic-drug maker Wockhardt Ltd.'s claim that Sepracor Inc. misled patent examiners by covering up rat study data related to sleep drug Lunesta, saying that the ...

Drugmaker Wockhardt has got off to an optimistic start this year with its novel antibiotic nafithromycin (Miqnaf) getting regulatory approval from the Central Drugs Standard Control Organization.

Wockhardt Bio AG – a subsidiary of Wockhardt Limited, a worldwide leader in discovery of novel antibiotics and Jiangxi Jemincare Group Company Limited, China, have partnered for Wockhardt’s novel ...

Shares of drug firm Wockhardt are in action even as the benchmark indices declined in early trade on Tuesday, December 2, 2025, amid uncertainty over repo rate cuts. The counter opened in green at Rs ...

The qualified institutional placement (QIP) offering of pharmaceutical firm Wockhardt Limited has attracted bids worth almost Rs 1,500 crore for the Rs 1,000 crore share sale, a majority of them from ...